133 related articles for article (PubMed ID: 35444013)
21. Neoadjuvant chemotherapy followed by radical surgery versus concurrent chemoradiotherapy in patients with FIGO stage IIB cervical cancer: the CSEM 006 study.
Tu H; Huang H; Ouyang Y; Liu Q; Xian B; Song K; Chen G; Shen Y; Liu J
Int J Gynecol Cancer; 2021 Jan; 31(1):129-133. PubMed ID: 32522771
[TBL] [Abstract][Full Text] [Related]
22. Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial.
Tax C; Abbink K; Rovers MM; Bekkers RLM; Zusterzeel PLM
Pilot Feasibility Stud; 2018; 4():27. PubMed ID: 29318031
[TBL] [Abstract][Full Text] [Related]
23. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
24. Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial.
Nunes de Arruda F; da Costa S; Bonadio R; Dornellas A; Pereira D; de Bock GH; Del Pilar Estevez Diz M
Int J Gynecol Cancer; 2020 Jun; 30(6):749-756. PubMed ID: 32321767
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
[TBL] [Abstract][Full Text] [Related]
26. Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?
Marnitz S; Köhler C; Roth C; Füller J; Hinkelbein W; Schneider A
Gynecol Oncol; 2005 Dec; 99(3):536-44. PubMed ID: 16126259
[TBL] [Abstract][Full Text] [Related]
27. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
28. Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Morgan RD; McNeish IA; Cook AD; James EC; Lord R; Dark G; Glasspool RM; Krell J; Parkinson C; Poole CJ; Hall M; Gallardo-Rincón D; Lockley M; Essapen S; Summers J; Anand A; Zachariah A; Williams S; Jones R; Scatchard K; Walther A; Kim JW; Sundar S; Jayson GC; Ledermann JA; Clamp AR
Lancet Oncol; 2021 Feb; 22(2):277-288. PubMed ID: 33357510
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
30. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
31. A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113).
Ray-Coquard I; Hatcher H; Bompas E; Casado A; Westermann A; Isambert N; Casali PG; Pratap S; Stark D; Valverde C; Anand A; Huizing M; Floquet A; Lindner L; Hermes B; Seddon B; Coens C; Jones R; Reed N
Int J Gynecol Cancer; 2020 Oct; 30(10):1633-1637. PubMed ID: 32546554
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
Tangjitgamol S; Tharavichitkul E; Tovanabutra C; Rongsriyam K; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara A; Hanprasertpong J; Chomprasert K; Wanglikitkoon S; Atjimakul T; Pariyawateekul P; Katanyoo K; Tanprasert P; Janweerachai W; Sangthawan D; Khunnarong J; Chottetanaprasith T; Supawattanabodee B; Lertsanguansinchai P; Srisomboon J; Isaranuwatchai W; Lorvidhaya V
J Gynecol Oncol; 2019 Jul; 30(4):e82. PubMed ID: 31074236
[TBL] [Abstract][Full Text] [Related]
33. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.
Plante M; van Trommel N; Lheureux S; Oza AM; Wang L; Sikorska K; Ferguson SE; Han K; Amant F
Int J Gynecol Cancer; 2019 Jun; 29(5):969-975. PubMed ID: 31101688
[TBL] [Abstract][Full Text] [Related]
34. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial.
Frumovitz M; Obermair A; Coleman RL; Pareja R; Lopez A; Ribero R; Isla D; Rendon G; Bernardini MQ; Buda A; Moretti-Marquez R; Zevallos A; Vieira MA; Zhu T; Land RP; Nicklin J; Asher R; Robledo KP; Gebski V; Ramirez PT
Lancet Oncol; 2020 Jun; 21(6):851-860. PubMed ID: 32502445
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma - a Role in Patients with Para-aortic Lymph Node Involvement? A 10-year Institutional Experience.
Green HM; Counsell N; Ward A; McCormack M
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e281-e290. PubMed ID: 35000828
[TBL] [Abstract][Full Text] [Related]
36. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
37. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
van den Heerik ASVM; Horeweg N; Nout RA; Lutgens LCHW; van der Steen-Banasik EM; Westerveld GH; van den Berg HA; Slot A; Koppe FLA; Kommoss S; Mens JWM; Nowee ME; Bijmolt S; Cibula D; Stam TC; Jurgenliemk-Schulz IM; Snyers A; Hamann M; Zwanenburg AG; Coen VLMA; Vandecasteele K; Gillham C; Chargari C; Verhoeven-Adema KW; Putter H; van den Hout WB; Wortman BG; Nijman HW; Bosse T; Creutzberg CL
Int J Gynecol Cancer; 2020 Dec; 30(12):2002-2007. PubMed ID: 33046573
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.
Tovanabutra C; Asakij T; Rongsriyam K; Tangjitgamol S; Tharavichitkul E; Sukhaboon J; Kridakara LCA; Paengchit K; Khunnarong J; Atjimakul T; Pariyawateekul P; Tanprasert P; Tungkasamit T; Lorvidhaya V
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2977-2985. PubMed ID: 34582670
[TBL] [Abstract][Full Text] [Related]
39. Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program.
RAINBO Research Consortium
Int J Gynecol Cancer; 2022 Dec; 33(1):109-17. PubMed ID: 36600534
[TBL] [Abstract][Full Text] [Related]
40. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer.
Frumovitz M; Querleu D; Gil-Moreno A; Morice P; Jhingran A; Munsell MF; Macapinlac HA; Leblanc E; Martinez A; Ramirez PT
J Minim Invasive Gynecol; 2014; 21(1):3-8. PubMed ID: 23911560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
